EPGL Med?@EPGLMed23m In summary, everything is status quo at EPGL despite market activities. Investors should take note.
EPGL Med?@EPGLMed32m remains very undervalued on the market at present and we will continue to progress the companies objectives forward.
EPGL Med?@EPGLMed33m remain in process as reported. Overall markets are jittery at present because of world and national events. EPGL Team believes EPGL...
EPGL Med?@EPGLMed35m including manufacturing and marketing of MPDD, R&D on several new devices under direction of David T. Markus PhD. Also, new patents...
EPGL Med?@EPGLMed37m EPGL Investor Alert: EPGL share structure remains the same at 499 million floating shares. EPGL remains progressing on all fronts...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.